Health

Pancreatic Cancer Trial Results

Updated 2026-10-23 10:35 UTC 1 source Positive

Tango Therapeutics reported an 82% tumor response rate in a trial of its combo therapy for advanced pancreatic cancer. The results were published by STAT News.

Coverage timeline — 1 article

STAT News

STAT+: Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer

An experimental drug combination led to tumor responses in 82% of patients with a certain type of advanced pancreatic cancer, Tango Therapeutics reported.

2026-10-23 10:30 UTC